Section 1 revises the criminal statute that governs controlled substances ‘‘on board’’ covered vessels by reorganizing where the ‘‘on board a covered vessel’’ language appears in 46 U.S.C. 70503(a). That change alters how the law describes covered conduct involving manufacture, distribution, possession with intent, and placement of controlled substances aboard vessels.
Separately, the bill directs the Commandant to overhaul Coast Guard policy on use of medications to treat overdoses and to ensure life‑saving medication is positioned across Coast Guard installations and operations; it also ties the service into an existing DoD tracking system, requires an interagency memorandum of understanding, and mandates a two‑year congressional briefing with specified data and privacy protections. The measures create operational, logistical, and data‑handling obligations for the Coast Guard and its civilian oversight partners.
At a Glance
What It Does
Requires the Coast Guard to adopt a written policy permitting use of medications to reverse opioid overdoses and to make those medications accessible across installations and operational environments; directs participation in the opioid tracking system established under the FY2024 NDAA and completion of an interagency MOU to enable access. It also obliges a congressional briefing with a 5‑year retrospective on opioid/fentanyl incidence and naloxone use.
Who It Affects
Coast Guard commanders, medical personnel and corpsmen, installation logistics and procurement teams, the department that houses the Coast Guard when not under the Navy (statutorily the Department of Homeland Security in peacetime), the Department of Defense for tracking‑system access, and congressional oversight committees.
Why It Matters
Positions the Coast Guard to treat opioid overdoses across afloat and shore settings and to feed data into a Department of Defense‑led tracking system—creating a precedent for military health data sharing by a non‑DoD service and imposing concrete readiness, training, and privacy compliance tasks.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a two‑track set of changes: a narrow statutory rephrasing tied to drug offenses on vessels, and a set of operational directives on opioid overdose response. On the operational side, the Commandant must adopt an updated policy that covers use of naloxone and comparable medications to treat opioid overdoses.
That policy must address both shore installations and every operational environment where Coast Guard personnel serve, which reaches small cutters, patrol boats, aircrews, and shore facilities.
The law attaches firm deadlines: the policy rewrite must be completed within one year of enactment; the Coast Guard must join the tracking system established under section 706 of the FY2024 National Defense Authorization Act (noted at 10 U.S.C. 1090 note) and finalize an MOU with the Secretary of the department in which the Coast Guard is operating when it is not operating as a service in the Navy and the Secretary of Defense within the earlier of one year after enactment or one year after the tracking system becomes available. The Commandant must also deliver a briefing to two congressional committees within two years that includes progress on implementation, the prevalence and incidence of illegal fentanyl and other controlled substances in the service over the prior five years, mitigation processes, the MOU status, and a review of naloxone uses in Coast Guard contexts during that five‑year window.Practical mechanics are emphasized: the legislation requires naloxone to be available across all installations and ‘‘in each operational environment’’ but leaves details—forms of medication, minimum quantities, training and authorization to administer, storage, and resupply—unwritten.
The bill also requires compliance with the Privacy Act and HIPAA‑related privacy rules when collecting and sharing data, and contains a rule saying a single facility’s naloxone stock can count as available to an entire installation if arrangements ensure access during operations. Those implementation details will drive procurement, training, logistics, and data‑handling work for Coast Guard leadership.
The Five Things You Need to Know
The Commandant must complete an updated medication‑for‑overdose policy within one year of enactment, addressing use of naloxone and similar drugs.
The updated policy must ensure naloxone or similar medication is available at every Coast Guard installation and ‘‘in each operational environment.’, The Coast Guard must participate in the opioid tracking system created under section 706 of the FY2024 NDAA (10 U.S.C. 1090 note) and finalize an access MOU with the relevant department secretary and the Secretary of Defense within the statute’s one‑year window tied to system availability.
Within two years the Commandant must brief the House Transportation & Infrastructure Committee and the Senate Commerce Committee on implementation progress, the five‑year prevalence/incidence of illegal fentanyl and other controlled substances in the service, overdose‑treatment uses of naloxone, mitigation processes, and MOU status.
The statute requires the Coast Guard to follow the Privacy Act and HIPAA privacy regulations when implementing these obligations and allows a single facility’s naloxone supply to serve an entire installation if guaranteed access arrangements exist.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Reframes where prohibited vessel conduct is described
The bill moves and tightens the placement of the phrase that ties prohibited conduct to being ‘‘on board a covered vessel.’’ By inserting location language directly into the enumerated offense elements (manufacture, distribution, possession with intent, and placement), Congress clarifies that the criminalized acts are specifically those that occur on or result in a controlled substance being placed on a covered vessel. Practically, that editing affects charging language and may change how prosecutors and defense counsel parse venue and conduct elements in cases alleging controlled‑substance offenses tied to vessels.
Mandate to update Coast Guard policy on overdose medication
This subsection creates an affirmative policy obligation for the Commandant to revise existing guidance to explicitly address use of medications (including naloxone) to treat drug overdoses. The requirement is time‑limited (one year), and it places the onus on headquarters to produce operational guidance that will inform training, authorization to administer, standing medical protocols, and supply chain decisions—areas currently governed by a mix of service guidance and medical authority.
Availability requirement across installations and operational environments
The updated policy must make naloxone or similar medications available at every Coast Guard installation and within every operational environment. The bill does not define minimum stock levels, shelf‑life management, authorized administrators, or forms (nasal vs. injectable), so implementation will require internal standards from the Coast Guard. The law’s rule that a single facility’s supply can count for an entire installation if access arrangements exist creates a logistical option for consolidated storage—but also a potential operational gap for deployed units unless access arrangements are robust.
Tracking system participation and interagency MOU to enable access
The Coast Guard must join the tracking system established under section 706 of the FY2024 NDAA, and the Secretary of the department in which the Coast Guard operates when not under the Navy and the Secretary of Defense must finalize an MOU to facilitate access. The timing tie—one year after enactment or one year after the tracking system is established, whichever is earlier—forces relatively quick integration planning. The practical tasks include legal review for data sharing, IT interoperability, role‑based access controls, and negotiating technical and privacy safeguards in the MOU.
Congressional briefing with specified data elements
Within two years the Commandant must brief two congressional committees on implementation status, prevalence and incidence of illegal fentanyl and other controlled substances during the prior five years, mitigation processes, actual instances where naloxone was used in Coast Guard contexts over that period, and the MOU status. The statutory list prescribes both quantitative (incidence/prevalence) and qualitative (process descriptions, MOU status) material, compelling the Coast Guard to assemble retrospective case data and forward‑looking implementation metrics.
Privacy requirement and installation access rule
The Commandant must comply with the Privacy Act and HIPAA‑related privacy regulations when carrying out the statute’s data‑collection and reporting duties. The rule of construction lets Coast Guard leadership treat a single facility’s naloxone stock as serving an entire installation if access arrangements guarantee availability during operations; this creates a compliance choice between decentralized caches and centralized repositories with guaranteed retrieval protocols.
This bill is one of many.
Codify tracks hundreds of bills on Defense across all five countries.
Explore Defense in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Coast Guard service members and personnel — they gain routine access to naloxone and similar medications across shore and operational settings, which reduces the risk of fatal opioid overdoses and preserves force readiness.
- Operational medical staff and corpsmen — clearer policy and required availability simplify protocols for emergency response and support standardized training and supply planning.
- Congressional oversight committees (House Transportation & Infrastructure; Senate Commerce) — the mandated briefing and specified data elements give committees enhanced visibility into substance use trends and service readiness measures.
- Public health and military surveillance entities — participation in the NDAA‑mandated tracking system provides additional data points for monitoring opioid exposure and response in a unique maritime/military population.
Who Bears the Cost
- The Coast Guard (logistics and procurement) — units must buy, store, track, rotate, and distribute naloxone stocks across shore and afloat units, and adopt training and documentation systems to support authorized administration.
- Coast Guard medical and legal staff — they must draft operational policy, create standing orders, negotiate MOU terms, ensure compliance with the Privacy Act and HIPAA‑related rules, and compile the five‑year briefing data.
- Departmental offices (DHS and DoD) — negotiating and implementing the MOU, enabling technical access to the tracking system, and resolving interagency legal/IT issues will require dedicated resources.
- Unit commanders and small‑unit crews — operational arrangements to ensure access when supplies are centralized may require changes to watch rotations, standby protocols, and rapid‑access procedures.
Key Issues
The Core Tension
The bill pits an urgent, life‑saving objective—widespread, rapid access to overdose reversal medication—against practical operational constraints and privacy/data‑sharing complexities: guaranteeing immediate access across all shipboard and shore environments will require decisions about stock levels, who can administer medication, how supplies are tracked and shared, and what data the Coast Guard may put into an external DoD system without violating service members’ privacy.
Several implementation gaps will determine whether the bill meaningfully reduces overdose deaths or simply creates paperwork. ‘‘Availability’’ is not defined: the statute does not specify minimum cache sizes, authorized administrators, mandated training frequency, or which formulation of naloxone satisfies the requirement. In austere or high‑tempo maritime operations—small cutters, boarding teams at sea, or underway aircrews—logistics (storage, temperature control, resupply windows) and authorization (who may carry and administer) will be the practical constraints.
The tracking system and MOU requirements raise data governance questions. The bill references the NDAA FY2024 tracking system but leaves technical access, role‑based privileges, retention rules, and cross‑departmental data sharing protocols to the forthcoming MOU.
That creates legal tension: the Commandant must comply with the Privacy Act and HIPAA‑related regulations while also feeding operational incidents into a DoD‑led system, potentially requiring complex redactions and narrow access controls. Finally, the statutory editing of the vessel‑offense language may have knock‑on effects for enforcement and prosecution—clarifying scope on one front could shift investigatory practices on another, but the bill contains no guidance about interagency operational coordination with maritime law enforcement partners.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.